GB201317935D0 - Novel compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis - Google Patents

Novel compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis

Info

Publication number
GB201317935D0
GB201317935D0 GB201317935A GB201317935A GB201317935D0 GB 201317935 D0 GB201317935 D0 GB 201317935D0 GB 201317935 A GB201317935 A GB 201317935A GB 201317935 A GB201317935 A GB 201317935A GB 201317935 D0 GB201317935 D0 GB 201317935D0
Authority
GB
United Kingdom
Prior art keywords
treatment
pharmaceutical compositions
cystic fibrosis
novel compounds
cystic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB201317935A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galapagos NV
Original Assignee
Galapagos NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galapagos NV filed Critical Galapagos NV
Priority to GB201317935A priority Critical patent/GB201317935D0/en
Publication of GB201317935D0 publication Critical patent/GB201317935D0/en
Priority to BR112016001984A priority patent/BR112016001984A2/en
Priority to ES14749783.8T priority patent/ES2691944T3/en
Priority to SI201431010T priority patent/SI3030568T1/en
Priority to TR2018/19434T priority patent/TR201819434T4/en
Priority to LTEP14749783.8T priority patent/LT3030568T/en
Priority to DK14749783.8T priority patent/DK3030568T3/en
Priority to US14/451,619 priority patent/US9133210B2/en
Priority to CA2919776A priority patent/CA2919776A1/en
Priority to AU2014304562A priority patent/AU2014304562B8/en
Priority to PE2016000230A priority patent/PE20160286A1/en
Priority to EP14749783.8A priority patent/EP3030568B1/en
Priority to EP18181140.7A priority patent/EP3486246A1/en
Priority to HUE14749783A priority patent/HUE040366T2/en
Priority to KR1020167006083A priority patent/KR20160040295A/en
Priority to RU2016107721A priority patent/RU2708690C2/en
Priority to PL14749783T priority patent/PL3030568T3/en
Priority to LU92577A priority patent/LU92577B1/en
Priority to CN201480044767.2A priority patent/CN105658655B/en
Priority to JP2016532663A priority patent/JP6425724B2/en
Priority to MX2016001602A priority patent/MX2016001602A/en
Priority to SG11201600891UA priority patent/SG11201600891UA/en
Priority to PCT/EP2014/066806 priority patent/WO2015018823A1/en
Priority to PT14749783T priority patent/PT3030568T/en
Priority to MYPI2016700390A priority patent/MY176814A/en
Priority to TW103127340A priority patent/TWI649325B/en
Priority to UY35700A priority patent/UY35700A/en
Priority to US14/808,200 priority patent/US9351955B2/en
Priority to IL243600A priority patent/IL243600B/en
Priority to PH12016500161A priority patent/PH12016500161A1/en
Priority to DO2016000041A priority patent/DOP2016000041A/en
Priority to CL2016000298A priority patent/CL2016000298A1/en
Priority to CR20160119A priority patent/CR20160119A/en
Priority to US15/143,967 priority patent/US9895347B2/en
Priority to HK16111157.8A priority patent/HK1222861A1/en
Priority to US15/865,963 priority patent/US10568867B2/en
Priority to HRP20181541TT priority patent/HRP20181541T1/en
Priority to CY181101337T priority patent/CY1121027T1/en
Ceased legal-status Critical Current

Links

GB201317935A 2013-08-08 2013-10-10 Novel compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis Ceased GB201317935D0 (en)

Priority Applications (38)

Application Number Priority Date Filing Date Title
GB201317935A GB201317935D0 (en) 2013-10-10 2013-10-10 Novel compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis
ES14749783.8T ES2691944T3 (en) 2013-08-08 2014-08-05 Tieno [2,3-c] pyrans as CFTR modulators
CN201480044767.2A CN105658655B (en) 2013-08-08 2014-08-05 Thieno [2,3-c] pyrans as CFTR conditioning agents
MX2016001602A MX2016001602A (en) 2013-08-08 2014-08-05 Thieno[2,3-c]pyrans as cftr modulators.
SI201431010T SI3030568T1 (en) 2013-08-08 2014-08-05 Thieno(2,3-c)pyrans as cftr modulators
TR2018/19434T TR201819434T4 (en) 2013-08-08 2014-08-05 Thieno [2,3-c] pyranes as Cftr modulators.
LTEP14749783.8T LT3030568T (en) 2013-08-08 2014-08-05 Thieno[2,3-c]pyrans as cftr modulators
DK14749783.8T DK3030568T3 (en) 2013-08-08 2014-08-05 THIENO [2,3-C] PYRANES AS CFTR MODULATORS
US14/451,619 US9133210B2 (en) 2013-08-08 2014-08-05 Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis
CA2919776A CA2919776A1 (en) 2013-08-08 2014-08-05 Thieno[2,3-c]pyrans as cftr modulators
JP2016532663A JP6425724B2 (en) 2013-08-08 2014-08-05 Thieno [2,3-C] pyrans as CFTR Modulators
PE2016000230A PE20160286A1 (en) 2013-08-08 2014-08-05 DERIVATIVES OF TENO [2,3-c] PYRANE AND ITS PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CYYSTIC FIBROSIS
EP14749783.8A EP3030568B1 (en) 2013-08-08 2014-08-05 Thieno[2,3-c]pyrans as cftr modulators
EP18181140.7A EP3486246A1 (en) 2013-08-08 2014-08-05 Thieno[2,3-c]pyrans as cftr modulators
HUE14749783A HUE040366T2 (en) 2013-08-08 2014-08-05 Thieno[2,3-c]pyrans as cftr modulators
KR1020167006083A KR20160040295A (en) 2013-08-08 2014-08-05 Thieno[2,3-c]pyrans as cftr modulators
RU2016107721A RU2708690C2 (en) 2013-08-08 2014-08-05 Derivatives of thieno[2,3-c]pyrans as cftr modulators
PL14749783T PL3030568T3 (en) 2013-08-08 2014-08-05 Thieno[2,3-c]pyrans as cftr modulators
LU92577A LU92577B1 (en) 2013-08-08 2014-08-05 New compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis
BR112016001984A BR112016001984A2 (en) 2013-08-08 2014-08-05 thieno [2,3-c] pyranes as cftr modulators
AU2014304562A AU2014304562B8 (en) 2013-08-08 2014-08-05 Thieno[2,3-c]pyrans as CFTR modulators
SG11201600891UA SG11201600891UA (en) 2013-08-08 2014-08-05 Thieno[2,3-c]pyrans as cftr modulators
MYPI2016700390A MY176814A (en) 2013-08-08 2014-08-05 Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis
PCT/EP2014/066806 WO2015018823A1 (en) 2013-08-08 2014-08-05 Thieno[2,3-c]pyrans as cftr modulators
PT14749783T PT3030568T (en) 2013-08-08 2014-08-05 Thieno[2,3-c]pyrans as cftr modulators
TW103127340A TWI649325B (en) 2013-08-08 2014-08-08 Novel compound for treating cystic fibrosis and pharmaceutical composition thereof
UY35700A UY35700A (en) 2013-08-08 2014-08-08 NEW COMPOUNDS AND THEIR PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CHYSICAL FIBROSIS
US14/808,200 US9351955B2 (en) 2013-08-08 2015-07-24 Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis
IL243600A IL243600B (en) 2013-08-08 2016-01-13 Thieno[2,3-c]pyrans as cftr modulators
PH12016500161A PH12016500161A1 (en) 2013-08-08 2016-01-22 Thieno[2,3-c]pyrans as cftr modulators
DO2016000041A DOP2016000041A (en) 2013-08-08 2016-02-03 5,5,7,7-TETRAMETHYL-5,7-DIHYDRO-4H-THENE[2,3-C]PYRAN-3-CARBOXAMIDE DERIVATIVE COMPOUNDS WHICH ARE MODULATORS OF THE CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR)
CL2016000298A CL2016000298A1 (en) 2013-08-08 2016-02-05 Compounds derived from thieno [2,3-c] pyran with modulating activity of the cystic fibrosis transmembrane conductance regulator (cftr); pharmaceutical composition that includes them; Useful in the treatment of cystic fibrosis.
CR20160119A CR20160119A (en) 2013-08-08 2016-03-08 NEW COMPOUNDS AND THEIR PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CHYSICAL FIBROSIS
US15/143,967 US9895347B2 (en) 2013-08-08 2016-05-02 Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis
HK16111157.8A HK1222861A1 (en) 2013-08-08 2016-09-22 Thieno[2,3-c]pyrans as cftr modulators cftr [23-c]
US15/865,963 US10568867B2 (en) 2013-08-08 2018-01-09 Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis
HRP20181541TT HRP20181541T1 (en) 2013-08-08 2018-09-27 Thieno[2,3-c]pyrans as cftr modulators
CY181101337T CY1121027T1 (en) 2013-08-08 2018-12-12 ΘEIENO [2,3-C] ΠYPANIA AS CFTR FORMERS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB201317935A GB201317935D0 (en) 2013-10-10 2013-10-10 Novel compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis

Publications (1)

Publication Number Publication Date
GB201317935D0 true GB201317935D0 (en) 2013-11-27

Family

ID=49679858

Family Applications (1)

Application Number Title Priority Date Filing Date
GB201317935A Ceased GB201317935D0 (en) 2013-08-08 2013-10-10 Novel compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis

Country Status (1)

Country Link
GB (1) GB201317935D0 (en)

Similar Documents

Publication Publication Date Title
HK1249507A1 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
EP2968285A4 (en) Compounds and methods for the treatment of cystic fibrosis
IL261444A (en) Novel compounds and pharmaceutical compositions thereof for the treatment of fibrosis
PL3021839T3 (en) Compositions for treatment of fibrosis
HK1208378A1 (en) Pharmaceutical composition for the treatment of fungal infections
GB201401086D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
EP3016944A4 (en) Compounds for treatment of cystic fibrosis
IL244622A0 (en) Compositions for the treatment of hypertension and/or fibrosis
IL244621A (en) Compositions for the treatment of hypertension and/or fibrosis
HUE037179T2 (en) Pharmaceutical compositions for the treatment of muscular disorders
GB201315072D0 (en) Novel compounds and pharmaceutical compositions thereoffor the treatment of proliferative disorders
GB201317935D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis
GB201317932D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis
GB201308137D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis
AU2013901209A0 (en) Compositions and methods for the treatment of cystic fibrosis
TH1601000722A (en) New compounds and their pharmaceutical compositions for treatment cystic fibrosis
AU2012900572A0 (en) Compositions and methods for the treatment of cystic fibrosis
GB201207064D0 (en) Pharmaceutical compositions comprising 15-hetre and methods of using the same

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)